Antibody Response to COVID-19 Vaccination in Adults With Hematologic Malignant Disease
Thomas Ollila, Shaolei Lu, Rebecca Masel, Adam Zayac, Kimberly J. Paiva, Ralph Rogers, Adam J. Olszewski
Abstract
This retrospective case series study examines immune response of adults with hematologic malignant disease who were vaccinated with 1 of 3 FDA-authorized COVID-19 vaccines between February and April of 2021.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)VaccinationAntibody responseHematologic diseaseAntibodyImmunology2019-20 coronavirus outbreakHematologic NeoplasmsDiseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibody therapyVirologyCancerInternal medicineOutbreakInfectious disease (medical specialty)Monoclonal antibodySARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsCOVID-19 Clinical Research Studies